India's market will grow quicker with regulation
This article was originally published in Clinica
Regulation can boost economic prosperity, through developing a competitive marketplace and an efficient, cost-effective healthcare sector. Milind Shah, managing director of Medtronic (India), says patients would also get the best available diagnosis and monitoring and that recover at a faster pace. Innovation and awareness drives are both important factors to medtech market development. The Indian market is growing at around 10-15% (cardiac devices: +20%), due to greater numbers of people who can afford private healthcare, and who are aware of healthcare options.
You may also be interested in...
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.